Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Renal Cell Carcinoma (RCC)”

900 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 900 results

Testing effectiveness (Phase 2)Study completedNCT00425204
What this trial is testing

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Who this might be right for
Colorectal CancerNon-Small Cell Lung CancerProstate Cancer+2 more
Amgen 31
Large-scale testing (Phase 3)Active Not RecruitingNCT04736706
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)

Who this might be right for
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC 1,854
Early research (Phase 1)Not Yet RecruitingNCT07716735
What this trial is testing

Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

Who this might be right for
Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more
Jonsson Comprehensive Cancer Center 18
Not applicableEnded earlyNCT00727532
What this trial is testing

Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Hereditary Clear Cell Renal Cell CarcinomaKidney Cancer
Northwestern University 9
Early research (Phase 1)Study completedNCT02646748
What this trial is testing

Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors

Who this might be right for
Colorectal Cancer (CRC)Endometrial CancerMelanoma+8 more
Incyte Corporation 159
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Early research (Phase 1)Study completedNCT00499135
What this trial is testing

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more
National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Not applicableStudy completedNCT00771147
What this trial is testing

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

Who this might be right for
Carcinoma, Renal CellCarcinoma, Renal Cell (Advanced)
Bayer 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07691476
What this trial is testing

Multicenter Single-Arm Clinical Trial of Zanzalintinib and Pembrolizumab in Subjects With Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Patients With Locally Advanced or Metastatic But Resectable Clear Cell Renal Cell Carcinoma
Yonsei University 48
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Study completedNCT02526017
What this trial is testing

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

Who this might be right for
Advanced Solid TumorsHead and Neck CancerPancreatic Cancer+4 more
Five Prime Therapeutics, Inc. 313
Not applicableStudy completedNCT02080650
What this trial is testing

Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

Who this might be right for
Prostate CancerRenal Cell CarcinomaBladder Cancer+5 more
Duke University 62
Testing effectiveness (Phase 2)Study completedNCT00005027
What this trial is testing

Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Kidney Cancer
Barbara Ann Karmanos Cancer Institute
Early research (Phase 1)Study completedNCT00356460
What this trial is testing

Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma

Who this might be right for
Carcinoma, Renal CellMelanoma
Genzyme, a Sanofi Company 29
Testing effectiveness (Phase 2)Looking for participantsNCT05931393
What this trial is testing

Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
RCCRenal Cell Carcinoma
University of Texas Southwestern Medical Center 18
Early research (Phase 1)Study completedNCT02762006
What this trial is testing

Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
Moshe Ornstein 29
Next Page